149 related articles for article (PubMed ID: 26376480)
1. The Potential Regulatory Mechanisms of miR-196a in Huntington's Disease through Bioinformatic Analyses.
Fu MH; Li CL; Lin HL; Tsai SJ; Lai YY; Chang YF; Cheng PH; Chen CM; Yang SH
PLoS One; 2015; 10(9):e0137637. PubMed ID: 26376480
[TBL] [Abstract][Full Text] [Related]
2. miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models.
Cheng PH; Li CL; Chang YF; Tsai SJ; Lai YY; Chan AW; Chen CM; Yang SH
Am J Hum Genet; 2013 Aug; 93(2):306-12. PubMed ID: 23810380
[TBL] [Abstract][Full Text] [Related]
3. miR-196a Enhances Neuronal Morphology through Suppressing RANBP10 to Provide Neuroprotection in Huntington's Disease.
Her LS; Mao SH; Chang CY; Cheng PH; Chang YF; Yang HI; Chen CM; Yang SH
Theranostics; 2017; 7(9):2452-2462. PubMed ID: 28744327
[TBL] [Abstract][Full Text] [Related]
4. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
5. miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural Cells.
Kunkanjanawan T; Carter RL; Prucha MS; Yang J; Parnpai R; Chan AW
PLoS One; 2016; 11(9):e0162788. PubMed ID: 27631085
[TBL] [Abstract][Full Text] [Related]
6. miR-196a enhances polymerization of neuronal microfilaments through suppressing IMP3 and upregulating IGF2 in Huntington's disease.
Yang HI; Huang PY; Chan SC; Tung CW; Cheng PH; Chen CM; Yang SH
Mol Ther Nucleic Acids; 2022 Dec; 30():286-299. PubMed ID: 36320323
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic analysis of a microRNA regulatory network in Huntington's disease.
Wang ZM; Dong XY; Cong SY
J Integr Neurosci; 2020 Dec; 19(4):641-650. PubMed ID: 33378838
[TBL] [Abstract][Full Text] [Related]
8. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
Crocker SF; Costain WJ; Robertson HA
Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.
Hoss AG; Kartha VK; Dong X; Latourelle JC; Dumitriu A; Hadzi TC; Macdonald ME; Gusella JF; Akbarian S; Chen JF; Weng Z; Myers RH
PLoS Genet; 2014 Feb; 10(2):e1004188. PubMed ID: 24586208
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
11. miR-196a provides antioxidative neuroprotection via USP15/Nrf2 regulation in Huntington's disease.
Chan SC; Tung CW; Lin CW; Tung YS; Wu PM; Cheng PH; Chen CM; Yang SH
Free Radic Biol Med; 2023 Nov; 209(Pt 2):292-300. PubMed ID: 37907121
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients.
Chang KH; Wu YR; Chen CM
Orphanet J Rare Dis; 2017 Dec; 12(1):185. PubMed ID: 29258536
[TBL] [Abstract][Full Text] [Related]
13. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P
Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555
[TBL] [Abstract][Full Text] [Related]
14. miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease.
Hart M; Diener C; Lunkes L; Rheinheimer S; Krammes L; Keller A; Meese E
Mol Med; 2023 Apr; 29(1):43. PubMed ID: 37013480
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease.
Wang F; Yang Y; Lin X; Wang JQ; Wu YS; Xie W; Wang D; Zhu S; Liao YQ; Sun Q; Yang YG; Luo HR; Guo C; Han C; Tang TS
Hum Mol Genet; 2013 Sep; 22(18):3641-53. PubMed ID: 23669348
[TBL] [Abstract][Full Text] [Related]
16. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.
Achour M; Le Gras S; Keime C; Parmentier F; Lejeune FX; Boutillier AL; Néri C; Davidson I; Merienne K
Hum Mol Genet; 2015 Jun; 24(12):3481-96. PubMed ID: 25784504
[TBL] [Abstract][Full Text] [Related]
17. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
18. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
19. Integrated analyses of zebrafish miRNA and mRNA expression profiles identify miR-29b and miR-223 as potential regulators of optic nerve regeneration.
Fuller-Carter PI; Carter KW; Anderson D; Harvey AR; Giles KM; Rodger J
BMC Genomics; 2015 Aug; 16(1):591. PubMed ID: 26265132
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation.
Hecht E; Zago M; Sarill M; Rico de Souza A; Gomez A; Matthews J; Hamid Q; Eidelman DH; Baglole CJ
Toxicol Appl Pharmacol; 2014 Nov; 280(3):511-25. PubMed ID: 25178717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
